Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2008 Giugno;50(2) > Panminerva Medica 2008 Giugno;50(2):161-3

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

REVIEWS  update on CARDIOLOGICAL ISSUES


Panminerva Medica 2008 Giugno;50(2):161-3

lingua: Inglese

Potential relationship between Helicobacter pylori and ischemic heart disease: any pathogenic model?

Berrutti M. 1, Pellicano R. 1, Fagoonee S. 2, Astegiano M. 1, Smedile A. 1, Saracco G. 1, Repici A. 3, Leone N. 4, Rizzetto M. 1

1 Department of Gastro-Hepatology S. Giovanni Battista Hospital (Molinette), Turin, Italy
2 Department of Biology Biochmestry and Genetics Molecular Biotechnology Center University of Turin, Turin, Italy
3 Gastroenterology, Humanitas Hospital, Rozzano, Milan, Italy
4 Gastroenterology, Gradenigo Hospital, Turin, Italy


FULL TEXT  ESTRATTI


Helicobacter pylori (H.pylori), causal agent of several gastroduodenal diseases, has been involved in diverse aspects of many extragastric manifestations, including ischemic heart disease (IHD). The present paper focuses on the potential pathogenic mechanisms relating H. pylori to IHD. Since H. pylori DNA has been detected in the coronary arteries only in sporadic occasions, and considering that long-term inflammation might raise cytokine levels in the bloodstream, an indirect pathway is more plausible. Moreover, the evidence that some strains of H. pylori induce platelet aggregation supports a role in the acute phase of IHD. In conclusion, because IHD is a multifactorial disease, it is evident that H. pylori is not the only cause. Thus, the definition of H. pylori or other infectious agents as culprits requires a multidisciplinary approach.

inizio pagina